The RIQAS Epstein Barr Virus (infectious mononucleosis) EQA programme is designed to monitor the performance of tests used to detect EBV virus antibodies. All samples are conveniently supplied liquid ready-to-use and are suitable for both quantitative and qualitative methods of analysis.
Liquid ready-to-use
100% human serum
Monthly reporting (6 samples per bi-annual distribution)
Submit results and view reports online via RIQAS.Net
Suitable for both quantitative and qualitative methods of analysis
Not accredited to ISO/IEC 17043
Cat No
Kit Size
Frequency
Cycle Start
Analytes
RQ9153
6 x 1ml
(1 sample to be tested per month. Samples shipped twice per year)
Randox Laboratories are providing the tools required to combat and detect COVID-19. We have solutions available for laboratory testing and consumer/company testing.
See the tools that Randox have to help diagnose and combat the virus.
Use the buttons below to direct you to the required pages.